Engineering Gut Microbiome to Target Breast Cancer



Status:Recruiting
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:12/2/2017
Start Date:October 11, 2017
End Date:August 2018
Contact:Jackie Joy
Email:joy.jacqueline@mayo.edu
Phone:904-953-8911

Use our guide to learn which trials are right for you!

The purpose of this study is to find out if using probiotics will help the body's immune
system react to breast cancer. New studies showed that diverse species of bacteria inside the
bowel might help improve immune system, particularly the ability of immune system to
recognize cancer. This study will investigate how probiotics will affect the subjects' immune
system on breast cancer.


Inclusion Criteria:

- Post-menopausal females ≥ 18 years of age

- Histologically confirmed adenocarcinoma of the breast ≥1.0 cm operable stage I-III

- Must have adequate organ function,

- Not receive systemic neoadjuvant therapy

- Be willing to provide tissue, blood, and stool samples for research study.

- Must not have taken any probiotics in the past 60 days prior to enrollment.

Exclusion Criteria:

- Patients with autoimmune disease, immune deficiency such as HIV, irritable bowel,
known diverticulosis, and other serious GI conditions at treating physician's
discretion will be excluded.
We found this trial at
1
site
4500 San Pablo Rd S
Jacksonville, Florida 32224
(904) 953-2000
Principal Investigator: Saranya Chumsri
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials